Process Development Scientist - NGS and Multiomics

About ** SeqMatic is a leading provider of next-generation sequencing (NGS) and other multiomics services. We are dedicated to advancing genomic research and providing innovative solutions to our clients. Our team is passionate about science and committed to delivering high-quality results.Position * We are seeking a highly motivated and experienced Process Development Scientist to join our dynamic team. The successful candidate will play a key role in the development and optimization of NGS-based assays for various applications, including clinical diagnostics, research, and drug development.Key *Design, develop, and optimize assays for various applications such as NGS, transcriptomics, single cell, spatial, and proteomics.Conduct experiments to validate and troubleshoot assay performance.Collaborate with cross-functional teams, including bioinformatics and clinical teams, to ensure successful assay development and implementation.Analyze and interpret experimental data, and present findings to internal and external stakeholders.Stay current with advancements in NGS technologies and assay development methodologies.Prepare technical reports, protocols, and documentation for regulatory submissions.Provide technical support and training to internal teams and external partners.Support other day to day activities in our NGS service lab including DNA extraction, library preparation, and sequencing.**Ph.D. or M.S. in Molecular Biology, Genetics, Biochemistry, or a related field.Minimum of 3 years of experience in assay development, preferably in an NGS related field.Strong understanding of NGS and multiomic technologies and applications.Proficiency in molecular biology techniques, including PCR and library preparation.Experience with bioinformatics tools and data analysis is a plus.Excellent problem-solving skills and attention to detail.Strong communication and interpersonal skills.Ability to work independently and as part of a team in a fast-paced environment.

Created: 2024-11-01